Belgian AI dental startup Relu lands €1.51 million to accelerate US expansion

August 6, 2026 at 01:20 PM UTC
EU-Startups
Original: EN
Belgian AI dental startup Relu lands €1.51 million to accelerate US expansion

Belgian AI dental startup Relu has secured a €1.51 million investment, signalling a significant step in its international expansion, particularly within the competitive US market. This funding, led by the North Carolina-based venture capital firm Dental Innovation Alliance (DIA), aims to bolster Relu's presence and accelerate the adoption of its automated dental design and planning solutions. The strategic investment underscores the growing impact of AI in niche healthcare sectors, demonstrating European innovation’s potential on a global scale.

Relu's core technology, Relu® Automate, leverages artificial intelligence to streamline complex dental workflows, addressing a critical shortage of skilled dental technicians. The platform analyzes 3D scans to automatically generate patient-specific designs for appliances like night guards, surgical guides, and crowns, significantly reducing manual computer-aided design (CAD) steps. This automation allows dental labs to increase production volume and speed without compromising the quality of essential dental prosthetics.

This technological advancement is particularly impactful for dental laboratories facing bottlenecks in production due to a scarcity of trained personnel. By automating design and administrative tasks, Relu empowers technicians to handle a greater number of cases, effectively removing a ceiling on lab growth. The company's commitment to regulatory compliance is evidenced by its CE certification (under EU MDR), FDA 510(k) clearance, and ISO 13485 certification, underscoring the safety and efficacy of its AI-driven medical device solutions.

Curated and translated by Europe Digital for our multilingual European audience.

Why this matters for European digital sovereignty

Belgian AI dental startup Relu has secured funding to expand into the US market, showcasing European innovation's global reach in niche healthcare sectors. This investment highlights the potential for European companies to leverage AI to address industry-wide challenges like skilled labor shortages. The company's CE certification under EU MDR further demonstrates its adherence to European regulatory standards.

Source Information

Publication: EU-Startups
Published: August 6, 2026 at 01:20 PM UTC
All rights remain with the original publisher.